Skip to main content
Dates: May 14 [Wed] - 16 [Fri], 2014
Venue: Tokyo Big Sight Organised by: Reed Exhibitions Japan Ltd.
Co-held with: 1st Personalised Medicine & Diagnostics Expo (IVD Japan 2014)
Professor and Chairman,
Dept. of Cardiovascular Surgery,
Osaka University Graduate School of Medicine
[Abstract]Cardiomyocyte sheet derived from iPS cells is a viable option as an autologous cell source for cardiac repair and a powerful tool for cardiovascular research. Newly developed cell sheet technology may be a promising armamentarium for complete regeneration of severely damaged myocardium.
Professor and Director,
Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science,
The University of Tokyo
[Abstract]Recent development of iPS cell technology has enabled generation of the patient's pluripotent stem cells (PSCs), opening up the way to regenerative medicine using the patient's own PSC-derived cells. In this presentation, I am going to describe some of our iPS technology-based projects aiming at future clinical use.
-(Honorifics omitted) Please note that the speakers and programs are subject to change.The photographic and video recording rights are reserved to the Show Management.About BIO tech 2013 email@example.com